Your browser doesn't support javascript.
loading
Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial.
Liu, Luke Tzu-Chi; Chiu, Cheng-Hsun; Chiu, Nan-Chang; Tan, Boon-Fatt; Lin, Chien-Yu; Cheng, Hao-Yuan; Lin, Meei-Yun; Lien, Chia-En; Chen, Charles; Huang, Li-Min.
  • Liu LT; Medigen Vaccine Biologics Corporation, Taipei, Taiwan.
  • Chiu CH; Department of Pediatrics, Chang Gung Children's Hospital, Chang Gung University College of Medicine, Taoyuan City, Taiwan.
  • Chiu NC; Department of Pediatrics, MacKay Children's Hospital, Taipei City, Taiwan.
  • Tan BF; Department of Pediatrics, National Taiwan University Hospital Hsinchu Branch, Hsinchu County, Taiwan.
  • Lin CY; Department of Pediatrics, Hsinchu MacKay Memorial Hospital, Hsinchu City, Taiwan.
  • Cheng HY; Medigen Vaccine Biologics Corporation, Taipei, Taiwan.
  • Lin MY; Medigen Vaccine Biologics Corporation, Taipei, Taiwan.
  • Lien CE; Medigen Vaccine Biologics Corporation, Taipei, Taiwan.
  • Chen C; Institute of Public Health, National Yang-Ming Chiao Tung University, Taipei City, Taiwan.
  • Huang LM; Medigen Vaccine Biologics Corporation, Taipei, Taiwan. charles@medigenvac.com.
NPJ Vaccines ; 7(1): 165, 2022 Dec 16.
Article en En | MEDLINE | ID: mdl-36526640
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Año: 2022 Tipo del documento: Article